Rani Therapeutics (NASDAQ: RANI)
$1.36
(-4.9%)
-$0.07
Price as of January 8, 2025, 4:00 p.m. ET
Rani Therapeutics Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Rani Therapeutics Company Info
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.